Evidence map›Paper›PMID 18332476›Full record

ReviewAmerican journal of Alzheimer's disease and other dementias

Alzheimer's and non-alzheimer's dementia: a critical review of pharmacological and nonpharmacological strategies.

Sahoo Saddichha, Vibha Pandey

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in American journal of Alzheimer's disease and other dementias. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. The potential role of dopamine D₃ receptor neurotransmission in cognition.European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · 2013
    Review
  6. Review
  7. Clinical features and multidisciplinary approaches to dementia care.Journal of multidisciplinary healthcare · 2011
    Article
  8. Review
  9. Designing leisure products for people with dementia: developing ''the Chitchatters'' game.American journal of Alzheimer's disease and other dementias · 2010
    Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sahoo SaddichhaCentral Institute of Psychiatry, Ranchi, Jharkhand, India. saddichha@gmail.com
Vibha Pandey

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveDementia is an age-related progressive neurodegenerative disorder afflicting about 5% of the world's population, and it is expected to grow dramatically in the future keeping in view our ageing society. Currently available medications appear to be able to produce moderate symptomatic benefits but do not to stop disease progression. In this article, the management of the disorder, including the currently available drugs as well as psychosocial strategies, is discussed.

methodsA computerized search on Pubmed from 1980 to 2006 was carried out and all articles evaluated and graded on NICE guidelines. RESULTS AND

conclusionsCurrently evaluated and accepted medications only bring about a reduction in the deteriorating course. A combination of pharmacotherapy and psychosocial management is the need of the hour.

Indexed as

Alzheimer DiseaseDementiaDisease ProgressionHumansTreatment Outcome

Identifiers

PMID18332476
PMCPMC10846026

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.